- Home
- DIBS vs PLRX Comparison
DIBS vs PLRX Comparison
Compare DIBS & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- PLRX
- Stock Information
- Founded
- DIBS 2000
- PLRX 2015
- Country
- DIBS United States
- PLRX United States
- Employees
- DIBS N/A
- PLRX N/A
- Industry
- DIBS Catalog/Specialty Distribution
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- DIBS Consumer Discretionary
- PLRX Health Care
- Exchange
- DIBS Nasdaq
- PLRX Nasdaq
- Market Cap
- DIBS 99.7M
- PLRX 93.3M
- IPO Year
- DIBS 2021
- PLRX 2020
- Fundamental
- Price
- DIBS $3.89
- PLRX $1.76
- Analyst Decision
- DIBS Hold
- PLRX Hold
- Analyst Count
- DIBS 1
- PLRX 11
- Target Price
- DIBS N/A
- PLRX $3.93
- AVG Volume (30 Days)
- DIBS 75.7K
- PLRX 1.0M
- Earning Date
- DIBS 11-07-2025
- PLRX 11-07-2025
- Dividend Yield
- DIBS N/A
- PLRX N/A
- EPS Growth
- DIBS N/A
- PLRX N/A
- EPS
- DIBS N/A
- PLRX N/A
- Revenue
- DIBS $88,640,000.00
- PLRX N/A
- Revenue This Year
- DIBS $2.87
- PLRX N/A
- Revenue Next Year
- DIBS $3.26
- PLRX N/A
- P/E Ratio
- DIBS N/A
- PLRX N/A
- Revenue Growth
- DIBS 3.21
- PLRX N/A
- 52 Week Low
- DIBS $2.30
- PLRX $1.10
- 52 Week High
- DIBS $4.39
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- DIBS 89.07
- PLRX 60.17
- Support Level
- DIBS $2.55
- PLRX $1.71
- Resistance Level
- DIBS $4.10
- PLRX $1.95
- Average True Range (ATR)
- DIBS 0.18
- PLRX 0.12
- MACD
- DIBS 0.13
- PLRX 0.02
- Stochastic Oscillator
- DIBS 87.74
- PLRX 66.00
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.